A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHs
Clinical trial NCT07764003 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07764003
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-10
- Primary completion
- 2027-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.